943722-24-5 Usage
Uses
Used in Organic Synthesis:
3-(N-Boc-aminomethyl)-5-bromopyridine is utilized as a building block in organic synthesis for the creation of various pharmaceuticals and biologically active compounds. Its Boc-protected amine group allows for selective reactions at the bromine-substituted position, facilitating the synthesis of diverse organic molecules.
Used in Drug Development:
In the pharmaceutical industry, 3-(N-Boc-aminomethyl)-5-bromopyridine serves as a key intermediate in drug development. Its unique structure and reactivity enable the production of complex organic molecules with potential therapeutic applications. The Boc protection of the amine group ensures that the compound can be selectively modified during the synthesis process, leading to the development of novel and effective drugs.
Used in the Production of Complex Organic Molecules:
3-(N-Boc-aminomethyl)-5-bromopyridine is employed as a valuable intermediate in the production of complex organic molecules. Its pyridine ring and bromine substituent provide opportunities for further functionalization and modification, allowing chemists to create a wide range of organic compounds with diverse properties and applications. The Boc-protected amine group ensures that these modifications can be carried out selectively, enhancing the versatility of the compound in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 943722-24-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,7,2 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 943722-24:
(8*9)+(7*4)+(6*3)+(5*7)+(4*2)+(3*2)+(2*2)+(1*4)=175
175 % 10 = 5
So 943722-24-5 is a valid CAS Registry Number.
943722-24-5Relevant academic research and scientific papers
SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS
-
Paragraph 0092; 0116, (2021/04/30)
Disclosed are 7-phenyl-2-aminoquinoline compounds that are shown to inhibit the biological activity of neuronal nitric oxide synthases (nNOSs). Also disclosed are pharmaceutical compositions comprising the compounds, and methods of using the compounds and
First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate
Cinelli, Maris A.,Reidl, Cory T.,Li, Huiying,Chreifi, Georges,Poulos, Thomas L.,Silverman, Richard B.
supporting information, p. 4528 - 4554 (2020/05/05)
Inhibition of neuronal nitric oxide synthase (nNOS), an enzyme implicated in neurodegenerative disorders, is an attractive strategy for treating or preventing these diseases. We previously developed several classes of 2-aminoquinoline-based nNOS inhibitor
Pleuromutilin derivatives such, its pharmaceutical composition and synthetic method and use thereof
-
, (2016/11/21)
The present invention relates to a class of pleuromytilin compounds represented by the following general formula (I), pharmaceutically acceptable salts and preparation methods thereof, and compositions comprising the compound represented by the general fo
(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING
-
Page/Page column 119, (2009/05/29)
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)
